Clinical Trial Update: The PROMISE Survey

View source ↗

Summary

The PROMISE Survey trial update provides status information on a University Hospital Basel study; it targets prolactinoma and pituitary adenoma and is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pituitary Adenoma
• Prolactinoma

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Prolactinoma, Pituitary Tumor | Status: ACTIVE_NOT_RECRUITING